These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 17977987

  • 1. Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma.
    Guo M, Gong Y, Deavers M, Silva EG, Jan YJ, Cogdell DE, Luthra R, Lin E, Lai HC, Zhang W, Sneige N.
    J Clin Microbiol; 2008 Jan; 46(1):274-80. PubMed ID: 17977987
    [Abstract] [Full Text] [Related]

  • 2. HPV in situ hybridization: impact of different protocols on the detection of integrated HPV.
    Hopman AH, Kamps MA, Smedts F, Speel EJ, Herrington CS, Ramaekers FC.
    Int J Cancer; 2005 Jun 20; 115(3):419-28. PubMed ID: 15688369
    [Abstract] [Full Text] [Related]

  • 3. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
    Hudelist G, Manavi M, Pischinger KI, Watkins-Riedel T, Singer CF, Kubista E, Czerwenka KF.
    Gynecol Oncol; 2004 Mar 20; 92(3):873-80. PubMed ID: 14984955
    [Abstract] [Full Text] [Related]

  • 4. Signal-amplified colorimetric in situ hybridization for assessment of human papillomavirus infection in cervical lesions.
    Birner P, Bachtiary B, Dreier B, Schindl M, Joura EA, Breitenecker G, Oberhuber G.
    Mod Pathol; 2001 Jul 20; 14(7):702-9. PubMed ID: 11455003
    [Abstract] [Full Text] [Related]

  • 5. Genital human papillomavirus testing by in situ hybridization in liquid atypical cytologic materials and follow-up biopsies.
    Bewtra C, Xie Q, Soundararajan S, Gatalica Z, Hatcher L.
    Acta Cytol; 2005 Jul 20; 49(2):127-31. PubMed ID: 15839614
    [Abstract] [Full Text] [Related]

  • 6. Detection of high-risk human papillomavirus subtypes in cervical glandular neoplasia by in situ hybridization.
    Sheng Z, Minato H, Sasagawa T, Nakada S, Kinoshita E, Kurose N, Nojima T, Makinoda S.
    Int J Clin Exp Pathol; 2013 Jul 20; 6(10):2168-77. PubMed ID: 24133595
    [Abstract] [Full Text] [Related]

  • 7. Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignancies.
    Theelen W, Litjens RJ, Vinokurova S, Haesevoets A, Reijans M, Simons G, Smedts F, Herrington CS, Ramaekers FC, von Knebel Doeberitz M, Speel EJ, Hopman AH.
    Hum Pathol; 2013 Nov 20; 44(11):2410-8. PubMed ID: 23968641
    [Abstract] [Full Text] [Related]

  • 8. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type.
    Swan DC, Tucker RA, Tortolero-Luna G, Mitchell MF, Wideroff L, Unger ER, Nisenbaum RA, Reeves WC, Icenogle JP.
    J Clin Microbiol; 1999 Apr 20; 37(4):1030-4. PubMed ID: 10074522
    [Abstract] [Full Text] [Related]

  • 9. p16INK4A immunoexpression and HPV in situ hybridization signal patterns: potential markers of high-grade cervical intraepithelial neoplasia.
    Kalof AN, Evans MF, Simmons-Arnold L, Beatty BG, Cooper K.
    Am J Surg Pathol; 2005 May 20; 29(5):674-9. PubMed ID: 15832093
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. HPV in situ hybridization signal patterns as a marker for cervical intraepithelial neoplasia progression.
    De Marchi Triglia R, Metze K, Zeferino LC, Lucci De Angelo Andrade LA.
    Gynecol Oncol; 2009 Jan 20; 112(1):114-8. PubMed ID: 19007972
    [Abstract] [Full Text] [Related]

  • 16. Comparison between in situ hybridization and real-time PCR technique as a means of detecting the integrated form of human papillomavirus 16 in cervical neoplasia.
    Fujii T, Masumoto N, Saito M, Hirao N, Niimi S, Mukai M, Ono A, Hayashi S, Kubushiro K, Sakai E, Tsukazaki K, Nozawa S.
    Diagn Mol Pathol; 2005 Jun 20; 14(2):103-8. PubMed ID: 15905694
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Application research on the flow-through hybridization and gene chip in human papillomavirus detection].
    Tao PP, Bian ML, Ou H, Chen QY, Li M, Liu J.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan 20; 41(1):43-7. PubMed ID: 16635328
    [Abstract] [Full Text] [Related]

  • 19. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM, Dirks DC, Poulter MD, Mills SE, Stoler MH.
    Am J Surg Pathol; 2017 May 20; 41(5):607-615. PubMed ID: 28403015
    [Abstract] [Full Text] [Related]

  • 20. [Detection of integration status of human papillomavirus 16 in cervical precancerous lesions].
    Chen QY, Bian ML, Chen ZH, Liu J.
    Zhonghua Yi Xue Za Zhi; 2005 Feb 16; 85(6):400-4. PubMed ID: 15854531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.